Conversely, Ascl1-OE GFP+ tumor cells had a significantly higher percentage of EdU+ cells at P30 (15%) and terminal stage (12%) compared to control and/or the single CKO tumors (Supplementary Fig. 3i–l). Here, ASCL1 is linked to neoplasm.